Kartos Therapeutics

RAPT Therapeutics

This biopharmaceutical company develops oral small-molecule therapies for patients with inflammatory diseases and cancer.

Atavistik Bio

This biotechnology company develops oral allosteric small molecule therapeutics for patients with rare hematological diseases and cancers.

Peloton Therapeutics

This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

K36 Therapeutics

This biotechnology company develops small molecule inhibitors targeting epigenetic pathways to treat cancers such as multiple myeloma and prostate cancer.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Opna Bio

This biopharmaceutical company develops small molecule oncology therapeutics for patients with multiple myeloma, myelofibrosis and other cancers.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.